MedPageToday -- Androgen deprivation therapy (ADT) leads to decay of bone microarchitecture and is a predisposing factor in bone fragility and fracture in prostate cancer patients, Australian researchers reported.
MedPageToday -- Androgen deprivation therapy (ADT) leads to decay of bone microarchitecture and is a predisposing factor in bone fragility and fracture in prostate cancer patients, Australian researchers reported.